Test Directory

Test Code
NIPT
Test Name
Noninvasive Prenatal Aneuploidy Screening
CPT Codes
81420
Included Tests

Noninvasive Prenatal Screening for trisomy 13, trisomy 18, trisomy 21 and sex chromosome aneuploidies.

Expected Turnaround Time
4-6 days
Clinical Utility

Noninvasive prenatal screening for trisomy 13, trisomy 18, trisomy 21 and sex chromosome aneuploidies. Recommended by ACOG for any pregnant woman, particularly those with a high-risk pregnancy.

Specimen and Container Info

Specimen: Whole Blood

Collection Container: Streck Cell-Free BCT

Specimen Volume: 7-10 mL

*For add-ons to this test, please contact Genomics

Collection Instructions
  1. Collect two Streck Cell-Free tubes.
  2. Draw blood using Vacutainer system (butterfly not appropriate); invert tube 10 times.
  3. Specimen must be collected at or greater than 10 weeks gestational age.
  4. *For add-ons to this test, please contact Genomics
Transport Instructions
  • Transport at room temperature.
  • Do not freeze or expose to extreme temperatures.
Stability Requirements

Room Temperature

5 days

*For add-ons to this test, please contact Genomics

Refrigerated

*For add-ons to this test, please contact Genomics

Frozen

*For add-ons to this test, please contact Genomics

Freeze/Thaw Cycles

*For add-ons to this test, please contact Genomics

Causes for Rejection
  • Specimen collected at <10 weeks gestation
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing of Cell-Free DNA
Performing Location
Genomics - Snowdrift
Alternate Names
  • NIPS
  • NIPT
  • cfDNA
  • Cell Free DNA screening
  • Noninvasive Prenatal Screening
Description

Noninvasive prenatal screening using cell-free DNA testing is currently the most sensitive and specific screening test for common fetal aneuploidies involving chromosomes 21, 18, 13, X, and Y with optional fetal sex detection. This test can be completed as early as 10 weeks gestational age. NIPS can provide expecting mothers the knowledge needed to make medical decisions regarding pregnancy, including the decision to pursue more invasive testing methods. NIPS is the best option for expecting patients to predict the likelihood of certain chromosome aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13), and sex chromosome aneuploidies. NIPS is now endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine for all patients, regardless of maternal age. This test is suitable for singleton and twin pregnancies and IVF with egg donor pregnancies (singleton and twin).

Testing Schedule
Routine, at least twice per week